Washington [US], October 4 (ANI): Researchers have come together to make critical advances in developing an effective vaccine against the human immunodeficiency virus (HIV).
California [US], July 31 (ANI): A new study from Scripps Research suggests that some proof-of-concept HIV vaccines in early human trials generate antibodies that actively hinder protection by degrading the vaccine's payload.
California [US], July 29 (ANI): Some proof-of-concept HIV vaccines in early human trials generate antibodies that actively hinder protection by degrading the vaccine's payload, suggests a new study from Scripps Research.
Washington [US], May 20 (ANI): A newly-identified group of antibodies that binds to a coating of sugars on the outer shell of HIV is effective in neutralizing the virus and points to a novel vaccine approach that could also potentially be used against SARS-CoV-2 and fungal pathogens, researc
Washington D.C. [USA], Sept. 13 (ANI): A recent study at The Scripps Research Institute (TSRI) shows that holes in HIV's defensive sugar shield could be important in designing an HIV vaccine.